Kelly Financial Services’s BioLife Solutions BLFS Stock Holding History

Kelly Financial Services’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-27	Closed	-$781	–	602
2020 Q3	$781	Hold	27	–	–	﹤0.01%	504
2020 Q2	$441	Hold	27	–	–	﹤0.01%	536
2020 Q1	$257	Hold	27	–	–	﹤0.01%	528
2019 Q4	$437	Hold	27	–	–	﹤0.01%	508
2019 Q3	$449	Hold	27	–	–	﹤0.01%	489
2019 Q2	$458	Hold	27	–	–	﹤0.01%	449
2019 Q1	$483	Buy	+27	New	+$429	﹤0.01%	443

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Kelly Financial Services's BLFS Position: Q4 2020 in Review

Kelly Financial Services sold out of BioLife Solutions (BLFS) in Q4 2020, closing a stake of 27 shares — an estimated $781 sold.

Kelly Financial Services first reported a position in BLFS in Q1 2019 and held it in 7 quarters. The position peaked at $781 in Q3 2020. 128 funds tracked by Wall St. Rank hold BLFS as of Q4 2020.

Kelly Financial Services reported no remaining BioLife Solutions position as of Q4 2020 after selling out during the quarter.
Kelly Financial Services sold 27 BioLife Solutions shares in Q4 2020, an estimated $781.
Kelly Financial Services first reported a position in BioLife Solutions in Q1 2019 and held it in 7 quarters.
Kelly Financial Services's BioLife Solutions position peaked at $781 in Q3 2020.
128 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2020.

Based on Kelly Financial Services's 13F filing for Q4 2020, filed 17 Jul 2024.